Physician profile
Paul Affleck
NPI 1902986078
$2,529.34
in general payments reported to CMS, 2019-2025
9 companies · $73.29 in 2025
The $73.29 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.19 · 2020: $1,218 · 2021: $164 · 2022: $129 · 2023: $108 · 2024: $782 · 2025: $73.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $750 · Food and Beverage: $193 · Education: $19.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $750.00 |
| Food and Beverage | $193.34 |
| Education | $19.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $1,200.00 | 2020 | |
| C. R. Bard, INC. & Subsidiaries | $750.00 | 2024 | Sensica Uo System |
| Chiesi USA, INC. | $304.85 | 2021-2025 | Cleviprex |
| Merck Sharp & Dohme LLC | $155.69 | 2019-2023 | Bridion |
| Acacia Pharma INC | $40.24 | 2021-2022 | |
| Avanos Medical | $22.74 | 2019 | |
| Octapharma USA, INC. | $20.20 | 2025 | Fibryga |
| Pajunk Medical Systems, LP | $18.09 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $17.53 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Affleck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.